Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer en SUNSHINE BIOPHARMA, INC. .
Fortuna: 7 003 $ al 31/03/2024
Perfil
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/03/2024 | 116 720 ( 0.12% ) | 7 003 $ | 31/03/2024 |
Cargos activos de Abderrazzak Merzouki
| Empresas | Cargo | Inicio |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 25/01/2024 |
| Imperial College London | Corporate Officer/Principal | 04/02/2011 |
Antiguos cargos conocidos de Abderrazzak Merzouki.
| Empresas | Cargo | Fin |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Formación de Abderrazzak Merzouki.
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
- Bolsa de valores
- Insiders
- Abderrazzak Merzouki
